PubMed 23788641
Referenced in: Kv2.2
Automatically associated channels: Kv2.1 , Kv2.2
Title: Control of Kv2.2 expression by pyruvate-isocitrate cycling regulates glucose-stimulated insulin secretion.
Authors: Mette V Jensen, Jonathan M Haldeman, Hengtao Zhang, Danhong Lu, Mark O Huising, Wylie W Vale, Hans E Hohmeier, Paul Rosenberg, Christopher B Newgard
Journal, date & volume: J. Biol. Chem., 2013 Jun 20 , ,
PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/23788641
Abstract
Recent studies have shown that the pyruvate-isocitrate cycling pathway, involving the mitochondrial citrate/isocitrate carrier and the cytosolic NADP-dependent isocitrate dehydrogenase (ICDc), is involved in control of glucose-stimulated insulin secretion (GSIS). Here we demonstrate that pyruvate-isocitrate cycling regulates expression of the voltage-gated potassium channel family member Kv2.2 in islet β-cells. siRNA-mediated suppression of ICDc, citrate/isocitrate carrier, or Kv2.2 expression impaired GSIS, and the effect of ICDc knockdown was rescued by re-expression of Kv2.2. Moreover, chronic exposure of β-cells to elevated fatty acids, which impairs GSIS, resulted in decreased expression of Kv2.2. Surprisingly, knockdown of ICDc or Kv2.2 increased rather than decreased outward K(+) current in the 832/13 β-cell line. Immunoprecipitation studies demonstrated interaction of Kv2.1 and Kv2.2, and co-overexpression of the two channels reduced outward K(+) current compared with overexpression of Kv2.1 alone. Also, siRNA-mediated knockdown of ICDc enhanced the suppressive effect of the Kv2.1-selective inhibitor stromatoxin1 on K(+) currents. Our data support a model in which a key function of the pyruvate-isocitrate cycle is to maintain levels of Kv2.2 expression sufficient to allow it to serve as a negative regulator of Kv channel activity.